179 related articles for article (PubMed ID: 35093070)
21. Malaria Surveillance - United States, 2018.
Mace KE; Lucchi NW; Tan KR
MMWR Surveill Summ; 2022 Sep; 71(8):1-35. PubMed ID: 36048717
[TBL] [Abstract][Full Text] [Related]
22. G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
Kheang ST; Ridley R; Ngeth E; Ir P; Ngor P; Sovannaroth S; Lek D; Phon S; Kak N; Yeung S
PLoS One; 2022; 17(10):e0275822. PubMed ID: 36264996
[TBL] [Abstract][Full Text] [Related]
23. Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.
Thriemer K; Bobogare A; Ley B; Gudo CS; Alam MS; Anstey NM; Ashley E; Baird JK; Gryseels C; Jambert E; Lacerda M; Laihad F; Marfurt J; Pasaribu AP; Poespoprodjo JR; Sutanto I; Taylor WR; van den Boogaard C; Battle KE; Dysoley L; Ghimire P; Hawley B; Hwang J; Khan WA; Mudin RNB; Sumiwi ME; Ahmed R; Aktaruzzaman MM; Awasthi KR; Bardaji A; Bell D; Boaz L; Burdam FH; Chandramohan D; Cheng Q; Chindawongsa K; Culpepper J; Das S; Deray R; Desai M; Domingo G; Duoquan W; Duparc S; Floranita R; Gerth-Guyette E; Howes RE; Hugo C; Jagoe G; Sariwati E; Jhora ST; Jinwei W; Karunajeewa H; Kenangalem E; Lal BK; Landuwulang C; Le Perru E; Lee SE; Makita LS; McCarthy J; Mekuria A; Mishra N; Naket E; Nambanya S; Nausien J; Duc TN; Thi TN; Noviyanti R; Pfeffer D; Qi G; Rahmalia A; Rogerson S; Samad I; Sattabongkot J; Satyagraha A; Shanks D; Sharma SN; Sibley CH; Sungkar A; Syafruddin D; Talukdar A; Tarning J; Ter Kuile F; Thapa S; Theodora M; Huy TT; Waramin E; Waramori G; Woyessa A; Wongsrichanalai C; Xa NX; Yeom JS; Hermawan L; Devine A; Nowak S; Jaya I; Supargiyono S; Grietens KP; Price RN
Malar J; 2018 Jun; 17(1):241. PubMed ID: 29925430
[TBL] [Abstract][Full Text] [Related]
24. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
[TBL] [Abstract][Full Text] [Related]
25. G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
Avalos S; Mejia RE; Banegas E; Salinas C; Gutierrez L; Fajardo M; Galo S; Pinto A; Mejia A; Fontecha G
Malar J; 2018 Nov; 17(1):415. PubMed ID: 30409136
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Plasmodium vivax malaria recurrence in Brazil.
Daher A; Silva JCAL; Stevens A; Marchesini P; Fontes CJ; Ter Kuile FO; Lalloo DG
Malar J; 2019 Jan; 18(1):18. PubMed ID: 30670020
[TBL] [Abstract][Full Text] [Related]
28. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
Taylor WRJ; Thriemer K; von Seidlein L; Yuentrakul P; Assawariyathipat T; Assefa A; Auburn S; Chand K; Chau NH; Cheah PY; Dong LT; Dhorda M; Degaga TS; Devine A; Ekawati LL; Fahmi F; Hailu A; Hasanzai MA; Hien TT; Khu H; Ley B; Lubell Y; Marfurt J; Mohammad H; Moore KA; Naddim MN; Pasaribu AP; Pasaribu S; Promnarate C; Rahim AG; Sirithiranont P; Solomon H; Sudoyo H; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Yamin FY; Dondorp A; Simpson JA; Baird JK; White NJ; Day NP; Price RN
Lancet; 2019 Sep; 394(10202):929-938. PubMed ID: 31327563
[TBL] [Abstract][Full Text] [Related]
29. Safety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly malaria vivax treatment.
Pereira D; Daher A; Zanini G; Maia I; Fonseca L; Pitta L; Ruffato R; Marchesini P; Fontes CJ
Malar J; 2016 Sep; 15():477. PubMed ID: 27639847
[TBL] [Abstract][Full Text] [Related]
30. Malaria Surveillance - United States, 2015.
Mace KE; Arguin PM; Tan KR
MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
[TBL] [Abstract][Full Text] [Related]
31. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
Abreha T; Hwang J; Thriemer K; Tadesse Y; Girma S; Melaku Z; Assef A; Kassa M; Chatfield MD; Landman KZ; Chenet SM; Lucchi NW; Udhayakumar V; Zhou Z; Shi YP; Kachur SP; Jima D; Kebede A; Solomon H; Mekasha A; Alemayehu BH; Malone JL; Dissanayake G; Teka H; Auburn S; von Seidlein L; Price RN
PLoS Med; 2017 May; 14(5):e1002299. PubMed ID: 28510573
[TBL] [Abstract][Full Text] [Related]
32. Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania.
Mwaiswelo R; Ngasala BE; Jovel I; Gosling R; Premji Z; Poirot E; Mmbando BP; Björkman A; Mårtensson A
Malar J; 2016 Jun; 15():316. PubMed ID: 27287612
[TBL] [Abstract][Full Text] [Related]
33. Radical cure for Plasmodium vivax malaria after G6PD qualitative testing in four provinces in Cambodia, results from Phase I implementation.
Lek D; Tsai YC; Hirano J; Sovannaroth S; Bunreth V; Vonn P; Vannthen O; Bunkea T; Samphornarann T; Sokomar N; Sarath M; Kheang ST; Wong E; Burbach MK; Hughes J; Rekol H
Malar J; 2024 Feb; 23(1):56. PubMed ID: 38395925
[TBL] [Abstract][Full Text] [Related]
34. Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region.
Pereira EA; Ishikawa EA; Fontes CJ
Malar J; 2011 Dec; 10():355. PubMed ID: 22165853
[TBL] [Abstract][Full Text] [Related]
35. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
36. Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India.
Anvikar AR; Sahu P; Pradhan MM; Sharma S; Ahmed N; Yadav CP; Pradhan S; Duparc S; Grewal Daumerie P; Valecha N
Am J Trop Med Hyg; 2022 Jan; 106(3):831-840. PubMed ID: 35008062
[TBL] [Abstract][Full Text] [Related]
37. In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine.
Villalobos-Salcedo JM; Tada MS; Kimura E; Menezes MJ; Pereira da Silva LH
Ann Trop Med Parasitol; 2000 Dec; 94(8):749-58. PubMed ID: 11214093
[TBL] [Abstract][Full Text] [Related]
38. Profile of adverse events in patients receiving treatment for malaria in urban Ghana: a cohort-event monitoring study.
Dodoo AN; Fogg C; Nartey ET; Ferreira GL; Adjei GO; Kudzi W; Sulley AM; Kodua A; Ofori-Adjei D
Drug Saf; 2014 Jun; 37(6):433-48. PubMed ID: 24788801
[TBL] [Abstract][Full Text] [Related]
39. Chloroquine-Primaquine Therapeutic Efficacy, Safety, and Plasma Levels in Patients with Uncomplicated
Mesa-Echeverry E; Niebles-Bolívar M; Tobón-Castaño A
Am J Trop Med Hyg; 2019 Jan; 100(1):72-77. PubMed ID: 30457097
[TBL] [Abstract][Full Text] [Related]
40. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
